Apr 12
|
Why Summit Therapeutics Inc. (SMMT) Surged On Friday?
|
Apr 6
|
2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade
|
Apr 5
|
We Think Summit Therapeutics (NASDAQ:SMMT) Can Easily Afford To Drive Business Growth
|
Apr 3
|
Esperion Therapeutics (ESPR) Down 15.8% Since Last Earnings Report: Can It Rebound?
|
Apr 3
|
3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months
|
Mar 31
|
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
|
Mar 31
|
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
|
Mar 30
|
Street Calls of the Week
|
Mar 28
|
Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?
|
Mar 14
|
Why Summit Therapeutics Stock Was Winning This Week
|
Mar 13
|
Is Summit Therapeutics Inc. (SMMT) the Best Multibagger Stock to Buy in 2025?
|
Mar 13
|
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
|
Feb 24
|
Pfizer sets sights on Summit’s bispecific in combo with its ADCs
|
Feb 24
|
Is Summit Therapeutics (SMMT) One of the Best Growth Stocks to Invest In According to Analysts?
|
Feb 24
|
Summit Therapeutics Stock Sinks as Firm Reports Widening Loss
|
Feb 24
|
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday
|
Feb 24
|
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024
|
Feb 24
|
Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)
|
Feb 23
|
Insider Stock Buying Reaches US$78.8m On Summit Therapeutics
|
Feb 18
|
Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025
|